JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JWN
4751
PUT
DELISTED
Nordstrom
JWN
| $241K | ﹤0.01% |
+11,400
| New | +$291K |
|
4752
PUT
BRC Group Holdings
RILY
$303M
| $241K | ﹤0.01% |
+5,700
| New | +$299K |
|
4753
CALL
Sea Limited
SE
$75.5B
| $241K | ﹤0.01% |
3,600
-164,500
| -98% | -$14M |
|
4754
Universal Technical Institute
UTI
$1.42B
| $240K | ﹤0.01% |
33,581
-15,936
| -32% | -$140K |
|
4755
Takeda Pharmaceutical
TAK
$55.5B
| $239K | ﹤0.01% |
17,052
-279
| -2% | -$3.98K |
|
4756
Credo Technology Group
CRDO
$49.6B
| $238K | ﹤0.01% |
20,352
+6,906
| +51% | +$80.3K |
|
|
AMPS
4757
DELISTED
Altus Power
AMPS
| $238K | ﹤0.01% |
37,703
+32,401
| +611% | +$216K |
|
4758
CALL
FIVE9
FIVN
$2.53B
| $237K | ﹤0.01% |
+2,600
| New | +$263K |
|
4759
ROBO Global Robotics & Automation Index ETF
ROBO
$2.13B
| $237K | ﹤0.01% |
5,269
-76
| -1% | -$3.8K |
|
4760
Arrow Financial
AROW
$723M
| $236K | ﹤0.01% |
7,879
-1,399
| -15% | -$42K |
|
4761
Amplify Alternative Harvest ETF
MJ
$112M
| $236K | ﹤0.01% |
3,393
-82
| -2% | -$7.59K |
|
|
TA
4762
DELISTED
TravelCenters of America LLC
TA
| $236K | ﹤0.01% |
6,851
-5,531
| -45% | -$205K |
|
|
VXRT
4763
DELISTED
Vaxart
VXRT
| $235K | ﹤0.01% |
67,047
+8,844
| +15% | +$33K |
|
4764
Medallion Financial
MFIN
$262M
| $233K | ﹤0.01% |
36,379
+4,182
| +13% | +$31.9K |
|
4765
Northeast Bank
NBN
$1.16B
| $233K | ﹤0.01% |
6,393
+2,481
| +63% | +$89.8K |
|
4766
Direxion Daily NYSE FANG+ Bull 2X ETF
FNGG
$143M
| $232K | ﹤0.01% |
5,000
| – | – |
|
4767
GeneDx Holdings
WGS
$2.36B
| $232K | ﹤0.01% |
5,557
+4,465
| +409% | +$303K |
|
|
AFMD
4768
DELISTED
Affimed
AFMD
| $231K | ﹤0.01% |
8,337
+1,447
| +21% | +$49.5K |
|
4769
Cullinan Oncology
CGEM
$1.26B
| $231K | ﹤0.01% |
17,995
-6,177
| -26% | -$70K |
|
4770
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.19B
| $231K | ﹤0.01% |
9,906
-6,791
| -41% | -$173K |
|
4771
Boston Omaha
BOC
$431M
| $230K | ﹤0.01% |
11,160
+1,407
| +14% | +$30.8K |
|
4772
Greystone Housing Impact Investors LP
GHI
$144M
| $230K | ﹤0.01% |
+13,045
| New | +$225K |
|
4773
Simplify Hedged Equity ETF
HEQT
$305M
| $230K | ﹤0.01% |
10,000
| – | – |
|
4774
Hyliion Holdings
HYLN
$734M
| $230K | ﹤0.01% |
71,455
+16,049
| +29% | +$56.3K |
|
4775
Similarweb
SMWB
$789M
| $230K | ﹤0.01% |
27,940
+27,640
| +9,213% | +$291K |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.